Sign in
Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia
Journal article   Open access   Peer reviewed

Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia

J McVernon, K Laurie, Helen Faddy, D O Irving, T Nolan, I Barr and A Kelso
Influenza and Other Respiratory Viruses, Vol.8(2), pp.194-200
2014
PMCID: PMC4186467
PMID: 24382379
pdf
Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia423.85 kBDownloadView
Published VersionCC BY V4.0 Open Access
url
https://doi.org/10.1111/irv.12225View
Published Version Open

Abstract

Blood donors immunity herd influenza human pandemics serology vaccination
Historical records of influenza pandemics demonstrate variability in incidence and severity between waves. The influenza A(H1N1)pdm09 pandemic was the first in which many countries implemented strain-specific vaccination to mitigate subsequent seasons. Serosurveys provide opportunity to examine the constraining influence of antibody on population disease experience.

Details

Metrics

2 File views/ downloads
17 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Infectious Diseases
Virology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image